Levels of Hematopoiesis Inhibitor N -Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background— Anemia is common in patients with chronic heart failure (CHF) and is associated with a poor prognosis. However, only a minority of patients with CHF have impaired renal function or underlying hematinic deficiencies. It has been shown that inhibition of the renin-angiotensin system is associated with the development of anemia. The aim of the present study was to determine possible mechanisms linking anemia to renin-angiotensin system activity in CHF patients. Methods and Results— We initially evaluated 98 patients with advanced stable CHF who were treated with ACE inhibitors (left ventricular ejection fraction, 28±1%; age, 69±1 years; 80% male), 10 of whom had an unexplained anemia (normal hematinics and no renal failure). These 10 anemic patients were matched with 10 nonanemic patients in terms of age and left ventricular ejection fraction. Serum ACE activity was 73% lower in anemic CHF patients compared with nonanemic CHF patients ( P =0.018). Moreover, serum of these patients inhibited in vitro the proliferation of bone marrow–derived erythropoietic progenitor cells of healthy donors by 17% ( P =0.003). Levels of the hematopoiesis inhibitor N -acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), which is almost exclusively degraded by ACE, were significantly higher in anemic CHF patients and were clearly correlated to erythroid progenitor cell proliferation ( r =−0.64, P =0.001). Conclusions— Serum ACE activity is markedly lower in anemic CHF patients, and serum of these patients inhibits hematopoiesis. The clear correlation between Ac-SDKP and proliferation of erythroid progenitor cells suggests an inhibitory role of Ac-SDKP on hematopoiesis in CHF patients, which may explain the observed anemia in patients treated with ACE inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ezekowitz, J. A., McAlister, F. A., & Armstrong, P. W. (2003) · Circulation · doi:10.1161/01.cir.0000052622.51963.fc · Cited by 866
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., & Borenstein, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01854-5 · Cited by 712
Anemia predicts mortality in severe heart failure
Mozaffarian, D., Nye, R., & Levy, W. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00425-x · Cited by 294
Anemia as a risk factor and therapeutic target in heart failure
Felker, G. M., Adams, K. F., Gattis, W. A., & O'Connor, C. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.070 · Cited by 255
Cited by
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Iron deficiency in chronic heart failure: an international pooled analysis
Klip, I. T., Comin-Colet, J., Voors, A. A., Ponikowski, P., Enjuanes, C., Banasiak, W., Lok, D. J., Rosentryt, P., Torrens, A., Polonski, L., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.017 · Cited by 736
Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies
Anand, I. S., & Gupta, P. (2018) · Circulation · doi:10.1161/circulationaha.118.030099 · Cited by 584
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Tang, Y.-D., & Katz, S. D. (2006) · Circulation · doi:10.1161/circulationaha.105.583666 · Cited by 415
Anemia and Chronic Heart Failure
Anand, I. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.044 · Cited by 314
Pascual-Figal, D. A., Bonaque, J. C., Redondo, B., Caro, C., Manzano-Fernandez, S., Sánchez-Mas, J., Garrido, I. P., & Valdes, M. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp109 · Cited by 244
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
van Veldhuisen, D. J., Anker, S. D., Ponikowski, P., & Macdougall, I. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.77 · Cited by 210
Self-citationMechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
van der Putten, K., Braam, B., Jie, K. E., & Gaillard, C. A. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0655 · Cited by 180
“ACE catalyzes the breakdown of N -acetyl-seryl-aspartyl-lysyl-proline, an inhibitor of erythropoiesis”
Methodvan der Meer, P., Postmus, D., Ponikowski, P., Cleland, J. G., O'Connor, C. M., Cotter, G., Metra, M., Davison, B. A., Givertz, M. M., Mansoor, G. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.050 · Cited by 177
Self-citationWong, M. M. Y., Tu, C., Li, Y., Perlman, R. L., Pecoits-Filho, R., Lopes, A. A., Narita, I., Reichel, H., Port, F. K., Sukul, N., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfz091 · Cited by 140
Metadata
- Authors
- van der Meer, P., Lipsic, E., Westenbrink, B. D., van de Wal, R. M. A., Schoemaker, R. G., Vellenga, E., van Veldhuisen, D. J., Voors, A. A., & van Gilst, W. H.
- Venue
- Circulation
- Published
- 2005-09-20
- Volume
- 112
- Issue
- 12
- Pages
- 1743-1747
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2111222598
- Cited by
- 141
- References
- 4
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.